Connecticut House Bill HB06697

Connecticut 2017 Regular Session

• Introduced: 1/24/17
• Refer: 1/24/17

Caption

An Act Requiring A Pharmacist To Review A Patient's Records In The Electronic Prescription Drug Monitoring System Prior To Dispensing An Opioid Medication.

Impact

If enacted, HB 06697 would amend section 21a-254 of the general statutes, adding a critical step to the prescription process that could potentially curtail the misuse and over-prescribing of opioids. This new requirement could lead to better patient outcomes through enhanced oversight, as pharmacists will be able to identify potential cases of abuse or harmful drug interactions before medications are dispensed. As a result, it may contribute to a broader strategy aimed at combating the opioid crisis statewide.

Summary

House Bill 06697 aims to enhance the monitoring of opioid prescriptions by requiring pharmacists to review a patient's records in the Electronic Prescription Drug Monitoring System (PDMP) before dispensing any opioid medication. The bill's primary purpose is to prevent opioid abuse, which has become a significant public health concern. By mandating this review process, the bill seeks to ensure that pharmacists are aware of a patient's prescribing history, allowing for more informed decisions regarding opioid dispensation.

Contention

While the bill's intent is largely supported due to its focus on public health and the prevention of substance abuse, there may be points of contention regarding its implementation. Concerns could arise about the additional workload placed on pharmacists, particularly in high-volume environments where time is constrained. Moreover, discussions might suggest differing opinions on whether this approach could adequately impact opioid dispensing practices or if other measures might be more effective in addressing the issue of opioid abuse.